Clinical Pharmacist
Innoviva Specialty Therapeutics
Thromboembolic Events in the Angiotensin II for the Treatment of High-Output Shock Phase 3 Trial
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.